✦ LIBER ✦

Phase II trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck

✍ Scribed by M. Degardin; P. Cappelaere; I. Krakowski; P. Fargeot; D. Cupissol; S. Brienza

Book ID: 116169175
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 201 KB
Volume: 32
Category: Article
ISSN: 0964-1955
DOI: 10.1016/0964-1955(95)00082-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pemetrexed disodium in recurrent locally

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

✍ Pivot, X; Raymond, E; Laguerre, B; Degardin, M; Cals, L; Armand, J P; Lefebvre, 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Advances in the management of recurrent

Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Dong M. Shin; Fadlo R. Khuri 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Phase II trial of piroxantrone in patien

Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck

✍ Sarah A. Taylor; Jacqueline Benedetti; David Schuller; Stephen P. Richman; Goron 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 161 KB

A Phase II Trial of Bryostatin-1 in Pati

A Phase II Trial of Bryostatin-1 in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

✍ David G. Pfister; John McCaffrey; Andrew J. Zahalsky; Gary K. Schwartz; Eric Lis 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 77 KB

Phase II trial of gemcitabine and paclit

Phase II trial of gemcitabine and paclitaxel (GEMTAX) combination in recurrent or advanced squamous cell carcinoma of the head and neck

✍ O. Kucuk; J. Fontana; J. Ensley 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 164 KB

A phase II trial of cisplatin and vinore

A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Enrique Espinosa; Pilar Zamora; Alfredo Millá; Serafin Morales; Raquel Molina; M 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv